Redsense Medical has secured a new order valued at 15.2 MSEK from one of the company’s US distributors.

"An order of this magnitude is of course extremely exciting and marks not only a special milestone as the largest in the company’s history, but also signifies a turning point in re-gaining momentum in the US market" says Pontus Nobréus CEO of Redsense Medical AB.

"The order will be delivered in partial which means an extremely strong finish to 2022 and a solid foundation for an excellent start of 2023. We are working with our distribution and supply chain partners on establishing a delivery plan and an inventory level framework moving forward. We have a clear focus on providing patient safety and this order can help us double down on our activities" continues Pontus Nobréus.

This information is information that Redsense Medical AB (publ) is obliged to make public pursuant to the EU Market Abuse Regulation and the Securities Markets Act. The information was submitted for publication, through the agency of the contact persons set out below, on December 02, 2022.

 Contact information

For more information, please contact: 
Pontus Nobréus
CEO
Telephone: +46 72-171 1264
E-mail: pontus.nobreus (at) redsensemedical.com

Redsense Medical AB (publ), 556646-4862

ABOUT REDSENSE MEDICAL

Redsense Medical is a corporate group with operations mainly in Europe and the United States. The company has developed the Redsense System, an innovation used for monitoring and alarm in the case of blood leakage in connection with a hemodialysis treatment. Redsense Medical solves one of the most serious remaining safety problems within hemodialysis – to quickly detect Venous Needle Dislodgement and catheter leakage to minimize blood leakage. The system consists of a patented fiber optic sensor, designed for either venous needle or central venous catheter, which is connected to an alarm unit. From the very start, the development of the company's technology has been based on the demands and safety requirements of healthcare providers in the dialysis sector.